What is UNOV's market cap?

$111.36M, based on the Nov 12 close of $41.63.

What is UNOV's P/E ratio?

29.7× trailing-twelve-month earnings of $3.75M.

What sector is UNOV in?

Healthcare, in the Pharmaceuticals industry.

Cboe BZX · UNOVHealthcarePharmaceuticals

Innovator U.S. Equity Ultra Buffer ETF - November (UNOV)

$41.63−0.12%

Close Nov 12, 2026 · split-adjusted

Nov 12, 2026$41.75▲ 10.27% in range

Nov 12, 2025Low $36.78 · High $41.95Nov 12, 2026

What changed · written from our data

As of Nov 12, 2026

Innovator U.S. Equity Ultra Buffer ETF - November closed at $41.63 on Nov 12, down 0.12%, 0.8% below its 52-week closing high. Volume of 47.6K shares was 1.29× its 20-day average (above normal).

Split-adjusted performance: -0.0% over one month, +4.5% over six months, +10.0% over one year.

In the quarter ended Sep 30, 2026, revenue was $7.30M, down 19.3% from a year earlier, with a net margin of 11.4%.

Short interest was 24.0K shares at the Oct 30 settlement, up 3345.6% from the prior report (1.2 days to cover).

Market cap$111.4M2.7M shares

Revenue · quarter$7.3M−19.3% YoY

Diluted EPS$0.00—

P/E · TTM29.7×P/S 3.3×

Net margin11.4%Gross 68.5%

Dividend yieldNone

52-week range36.78 – 41.95−0.8% from high

Volume47.6K1.29× 20-day avg

Volatility · 60d7.0%Annualised

Short % of float—1.2 days to cover

Net cash$2.7MCash $2.7M

Next earnings—Not scheduled

Split-adjusted performance

1W +1.6%1M 0.0%3M +1.3%6M +4.5%YTD +9.4%1Y +10.0%3Y +37.0%5Y +41.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 417 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −26.3%, revenue growth +9.3%, net margin −35.1%, P/E 16.5×.

Short interest

Details →

Shares short24.0K+3345.6% vs prior

Days to cover1.2Settled Oct 30

% of float—

Short vol. 10d76.5%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
UNOVInnovator U.S. Equity Ultra Buffer ETF - November	$41.63	−0.12%	+4.5%	−19.3%	11.4%	29.7	$111.4M
EYEGAB Corporate Bond ETF	$33.54	−0.67%	−4.7%	—	—	—	$26.8M	Compare

News about Innovator U.S. Equity Ultra Buffer ETF - November

All news →

No recent articles focused on Innovator U.S. Equity Ultra Buffer ETF - November.

Quick answers

What is UNOV's market cap?: $111.36M, based on the Nov 12 close of $41.63.
What is UNOV's P/E ratio?: 29.7× trailing-twelve-month earnings of $3.75M.
What sector is UNOV in?: Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology